Hemophilia A in Saudi Arabia
How patients in Saudi Arabia access treatment for hemophilia a via Named Patient Program.
About Hemophilia A
Hematology
Treatment access in Saudi Arabia
The Saudi Food and Drug Authority (SFDA) operates a Personal Import / Unregistered Medicine pathway for named patients, typically requiring physician justification and hospital ethics-committee review.
For patients in Saudi Arabia with hemophilia a whose required therapy is not locally registered, a Named Patient Program pathway typically applies.
How Reserve Meds supports patients with hemophilia a in Saudi Arabia
- Patient or physician contacts us with disease details and therapy requested.
- We verify eligibility in Saudi Arabia and confirm US supply.
- Treating physician in Saudi Arabia issues prescription and justification.
- We file Saudi Arabia-specific NPP/personal-import paperwork.
- We source the drug from a DSCSA-compliant US specialty wholesaler.
- Cold-chain shipment to the patient's physician or hospital pharmacy in Saudi Arabia.
Patient support throughout
- Case manager from request through delivery.
- Documentation translation where needed.
- Physician-to-physician support for clinical justification.
- Re-supply coordination for chronic therapy.